Active Ingredient History
FLUORIDE ION F-18 (as sodium fluoride F-18) is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity. FLUORIDE ION F-18 normally accumulates in the skeleton in an even fashion, with greater deposition in the axial skeleton (e.g. vertebrae and pelvis) than in the appendicular skeleton and greater deposition in the bones around joints than in the shafts of long bones. Increased FLUORIDE ION F-18 deposition in the bone can occur in areas of increased osteogenic activity during growth, infection, malignancy (primary or metastatic) following trauma, or inflammation of the bone. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acne Vulgaris (Phase 3)
Aortic Valve Stenosis (Phase 2)
Bacterial Infections (Phase 3)
Breast Neoplasms (Phase 3)
Cariostatic Agents (Phase 4)
Carotid Stenosis (Phase 2)
Chronic Periodontitis (Phase 3)
Coronary Artery Disease (Phase 4)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 2)
Dental Caries (Phase 4)
Dental Caries Susceptibility (Phase 4)
Dental Enamel Hypoplasia (Phase 3)
Dental Plaque (Phase 4)
Dentin Desensitizing Agents (Phase 2/Phase 3)
Dentin Sensitivity (Phase 4)
Denture, Partial (Phase 3)
Dermatology (Phase 2/Phase 3)
Diabetes Mellitus, Type 2 (Phase 4)
Down Syndrome (Phase 2)
Fluorides, Topical (Phase 4)
Fluorosis, Dental (Phase 4)
General Surgery (Phase 4)
Gingival Diseases (Phase 3)
Gingivitis (Phase 4)
Healthy Volunteers (Phase 3)
Hypersensitivity (Phase 2/Phase 3)
Infections (Phase 3)
Minerals (Phase 2/Phase 3)
Mouth (Phase 4)
Mucositis (Phase 3)
Multiple Myeloma (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 4)
Oral Hygiene (Phase 4)
Osteoporosis, Postmenopausal (Phase 2)
Peri-Implantitis (Phase 3)
Periodontal Diseases (Phase 4)
Periodontitis (Phase 3)
Plaque, Atherosclerotic (Phase 4)
Prostatic Neoplasms (Phase 2)
Root Caries (Phase 1)
Saliva (Phase 3)
Smoldering Multiple Myeloma (Phase 2)
Sodium Fluoride (Phase 2)
Stomatognathic Diseases (Early Phase 1)
Tooth (Phase 1/Phase 2)
Tooth Abnormalities (Phase 4)
Tooth Demineralization (Phase 4)
Tooth Erosion (Phase 3)
Xerostomia (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue